Anticipated shortage
Tamiflu 75 mg capsules
oseltamivir phosphate · 75 mg capsule
Tamiflu
- Reported
- 20 January 2025
- Expected resolution
- 31 August 2025
- TGA reference
- TGA-MSI-2025-001
- Sponsor
- Roche Products Pty Limited
Reason for shortage
Anticipated shortage due to projected influenza season demand outpacing current stock levels.
What to do
- 1.Ensure you have adequate stock — Collect your current prescription promptly to build a small buffer before the anticipated shortage begins.
- 2.Speak with your prescriber proactively — Discuss alternative options now, before the shortage occurs, so a plan is in place.
- 3.Monitor TGA updates — Anticipated shortages may be resolved before they become active. Check the TGA MSI database regularly.
Suggested alternatives
Same or related therapeutic class. Always discuss with your doctor or pharmacist before switching.
- Relenza inhaler — zanamivir 5 mg/dose (inhaled)
- Xofluza — baloxavir marboxil (single-dose tablet, not PBS listed)
Official resources
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.